Literature DB >> 26461038

Role of microRNA‑503 in the suppression of osteosarcoma cell proliferation and migration via modulation of fibroblast growth factor 2.

Bing Wu1, Wenzhi Bi1.   

Abstract

The present study aimed to investigate the expression levels of microRNA (miR)‑503 in osteosarcoma (OS), as well as to assess the effects and underlying mechanisms of miR‑503 on cell proliferation, apoptosis, migration and invasion of OS cells. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to determine the expression levels of miR‑503 in OS and adjacent normal bone tissue samples. Proliferation, apoptosis, migration and invasion assays were performed to determine the effects of miR‑503 on OS cells. The expression levels of miR‑503 were significantly decreased in OS tissue samples, as compared with normal tissue samples (P<0.0001). Upregulation of miR‑503 significantly inhibited proliferation and induced cell apoptosis, as compared with the negative controls. The results of the present study also demonstrated that miR‑503 significantly decreased the migration and invasion ability of the OS cells, which may be mediated by the inhibition of fibroblast growth factor 2 (FGF2). In conclusion, the present study demonstrated that expression of miR-503 was involved in the inhibition of cellular proliferation, and induced apoptosis of the OS cells. In addition, miR‑503 was able to inhibit the migration and invasion ability of OS cells, likely via the inhibition of FGF2 expression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26461038     DOI: 10.3892/mmr.2015.4399

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  miR-105/Runx2 axis mediates FGF2-induced ADAMTS expression in osteoarthritis cartilage.

Authors:  Quanbo Ji; Xiaojie Xu; Yameng Xu; Zhongyi Fan; Lei Kang; Ling Li; Yingchun Liang; Jing Guo; Tian Hong; Zhongli Li; Qiang Zhang; Qinong Ye; Yan Wang
Journal:  J Mol Med (Berl)       Date:  2016-01-27       Impact factor: 4.599

3.  MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor.

Authors:  Zili Wang; Chenhuang Zheng; Kunqi Jiang; Jinshen He; Xu Cao; Song Wu
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

4.  MiR-503 Promotes Bone Formation in Distraction Osteogenesis through Suppressing Smurf1 Expression.

Authors:  Yuxin Sun; Jia Xu; Liangliang Xu; Jinfang Zhang; Kaiming Chan; Xiaohua Pan; Gang Li
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

5.  MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma.

Authors:  Ping Chen; Tianrong Xing; Qingdong Wang; Ai Liu; Haiping Liu; Yuhong Hu; Yanjia Ji; Ying Song; Dongwei Wang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

6.  HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis.

Authors:  Zheng Wang; Nan Zhou; Wengang Wang; Yangke Yu; Lei Xia; Ning Li
Journal:  Arthritis Res Ther       Date:  2021-03-09       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.